IPFGut health
What this study is
The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).
Study details
- Sponsor
- National Jewish Health
- Conditions
- IPF · Reflux
- Enrolling
- 60 people
- Starts
- 2018-08-01
- Est. completion
- 2026-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 40 Years – 95 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Diagnosis of IPF
- Age 40-95
- Able to read, speak, and understand English
- If subjects are currently taking medication for reflux or GERD, they much be on a stable does for at least 4 weeks prior to consent.
You can't join if
- Patients who do not meet all inclusion criteria
- Pregnant females
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openNational Jewish Health
Denver, Colorado, United States
- Tara Churney, MPH · Contact303-398-1996ILDresearch@njhealth.org
Recruiting
Study team
Sponsor
National Jewish Health
Study ID HS-3130
Principal investigator
Matthew Koslow, DO
National Jewish Health
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.